Literature DB >> 12788311

Urinary tract stones--Part II: current status of treatment.

C Sandhu1, K M Anson, U Patel.   

Abstract

The majority of renal and ureteric stones are now managed by minimally invasive techniques, for example nephrostomy, ureteral stents, extracorporeal shockwave lithotripsy or percutaneous nephrolithotomy. A multi-disciplinary approach is necessary, and this review examines the status of modern stone therapy and the contribution of the radiology department.

Mesh：

Year:  2003        PMID： 12788311     DOI： 10.1016/s0009-9260(03)00104-1

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


  6 in total

Review 1.  [Imaging techniques and their impact in treatment management of patients with acute flank pain].

Authors:  A Grosse; C A Grosse; J Mauermann; G Heinz-Peer
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

Review 2.  Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.

Authors:  Klaus Armin Hausegger; Horst Rupert Portugaller
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

3.  Health-related quality of life in patients undergoing lithotripsy for urinary stones.

Authors:  Toshifumi Kurahashi; Hideaki Miyake; Masashi Shinozaki; Nobutoshi Oka; Atsushi Takenaka; Isao Hara; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2007-06-30       Impact factor: 2.370

Review 4.  [Imaging modalities and therapy options in patients with acute flank pain].

Authors:  A Grosse; C Grosse
Journal:  Radiologe       Date:  2014-07       Impact factor: 0.635

5.  Study of quality of life and its determinants in patients after urinary stone fragmentation.

Authors:  Mostafa A Arafa; Danny M Rabah
Journal:  Health Qual Life Outcomes       Date:  2010-10-19       Impact factor: 3.186

6.  Three-dimensional CT pyelography for planning of percutaneous nephrostolithotomy: accuracy of stone measurement, stone depiction and pelvicalyceal reconstruction.

Authors:  Uday Patel; Richard Miles Walkden; Khurshid R Ghani; Ken Anson
Journal:  Eur Radiol       Date:  2009-01-14       Impact factor: 5.315
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.